Cytokine modulation of Th1/Th2 phenotype differentiation in directly alloresponsive CD4+ human T cells

Transplantation

Volumn 62, Issue 8, 1996, Pages 1095-1101

  Pawelec, Graham ^a   Rehbein, Arnika ^a   Schlotz, Elke ^a   Friccius, Hilke ^a   Pohla, Heike ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOIMMUNITY; ANTIGEN RECOGNITION; ARTICLE; CELL DIFFERENTIATION; GRAFT REJECTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIBODIES; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL DIVISION; CLONE CELLS; CYTOKINES; GRAFT REJECTION; HUMANS; INTERLEUKIN-10; INTERLEUKIN-4; ISOANTIGENS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; PHENOTYPE; TH1 CELLS; TH2 CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0029957587     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199610270-00013     Document Type: Article

References (24)

1. Sayegh MH, Watschinger B, Carpenter CB. Mechanisms of T cell recognition of alloantigen - the role of peptides. Transplantation 1994; 57: 1295.
2. Braun MY, McCormack A, Webb G, Batchelor JR. Mediation of acute but not chronic rejection of MHC-incompatible rat kidney grafts by alloreactive CD4 T-cells activated by the direct pathway of sensitization. Transplantation 1993; 55: 177.
3. Mosmann TR, Coffman RL. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv Immunol 1989; 46: 111.
4. Panina-Bordignon P, Corradin G, Roosnek E, Sette A, Lanzavecchia A. Recognition by class-II alloreactive T-cells of processed determinants from human serum proteins. Science 1991; 252: 1548.
5. Lechler RI, Heaton T, Barber L, Bal V, Batchelor JR, Lombardi G. Molecular mimicry by major histocompatrhility complex molecules and peptides accounts for some alloresponses. Immunol Lett 1992; 34: 63.
6. Adibzadeh M, Friccius H, Bornhak S, et al. Role of three quantitatively dominant endogenous peptides from HLA-DRB1*0401 molecules in class II-specific alloreactivity. Transplant Immunol 1994; 2: 293.
7. Charlton B, Auchincloss H, Fathman CG. Mechanisms of transplantation tolerance. Annu Rev Immunol 1994; 12: 707.
8. Pawelec G. Suppressor cells in transplantation immunology: do recent advances in T cell immunobiology and cytokine networking contribute to the solution of an old conundrum? Transplant Immunol 1993; 1: 172.
9. Nickerson P, Steurer W, Steiger J, Zheng XX, Steele AW, Strom TB. Cytokines and the Th1/Th2 paradigm in transplantation. Curr Opin Immunol 1994; 6: 757.
10. Schaudt K, Pawelec G. Computerised transfer and processing of data from experiments measuring cellular proliferation by incorporation of tritiated thymidine. J Immunol Methods 1991; 138: 155.
11. Pawelec GP, Rehbein A, Schaudt K, Busch FW. IL-4-responsive human helper T cell clones are resistant to growth inhibition by tumor necrosis factor-α. J Immunol 1989; 143: 902.
12. Pawelec G, Pohla H, Scholtz E, et al. Interleukin 10 is a human T cell growth factor in vitro. Cytokine 1995; 7: 355.
13. Taga K, Cherney B, Tosato G. IL-10 inhibits apoptotic cell death in human T-cells starved of IL-2. Int Immunol 1993; 5: 1599.
14. Sad S, Mosmann TR. Single IL-2-secreting precursor CD4 T cell can develop into either Th1 or Th2 cytokine secretion phenotype. J Immunol 1994; 153: 3514.
15. Mocci S, Coffman RL. Induction of a Th2 population from a polarized Leishmania-specific Th1 population by in vitro culture with IL-4. J Immunol 1995; 154: 3779.
16. Hilkens CMU, Vermeulen H, Van Neerven RJJ, Snijdewint FGM, Wierenga EA, Kapsenberg ML. Differential modulation of T helper type 1 (Th1) and T helper type 2 (Th2) cytokine secretion by prostaglandin E(2) critically depends on interleukin-2. Eur J Immunol 1995; 25: 59.
17. Yssel H, Fasler S, De Vries JE, Malefyt RD. IL-12 transiently induces IFN-gamma transcription and protein synthesis in human CD4-t- allergen-specific T(h)2 T-cell clones. Int Immunol 1994; 6: 1091.
18. Decarli M, Berthold S, Fickenscher H, et al. Immortalization with herpesvirus saimiri modulates the cytokine secretion profile of established Th1 and Th2 human T-cell clones. J Immunol 1993; 151: 5022.
19. 1 during lymphocyte activation: a study with a monoclonal antibody-based ELISA. J Immunol 1990; 145: 1415.
20. Cerwenka A, Bevec D, Majdic O, Knapp W, Holter W. TGF-beta 1 is a potent inducer of human effector T cells. J Immunol 1994; 153: 4367.
21. Lee HM, Rich S. Co-stimulation of T-cell proliferation by transforming growth factor-beta 1. J Immunol 1991; 147: 1127.
22. De Jong R, Van Lier RAW, Ruscetti FW, Schmitt C, Debre P, Mossalayi MD. Differential effect of transforming growth factor-beta 1 on the activation of human naive and memory CD4(+) T lymphocytes. Int Immunol 1994; 6: 631.
23. Del Prete G, Decarli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S. Human IL-10 is produced by both type-1 helper (Th1) and Type-2 helper (Th2) T-cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993; 150: 353.
24. Yssel H, Malefyt RD, Roncarolo MG, et al. IL-10 is produced by-subsets of human CD4+ T-cell clones and peripheral blood T-cells. J Immunol 1992; 149: 2378.